|
|
|
40
|
30612
|
RHOPHYLAC 300MCG INJ (CSL/AHI) ANTI-D IMMUNOG
|
ANTI-D IMMUNOGLOBULIN
|
RHOPHYLAC
|
2ML AMP
|
BQ
|
108.73
|
108.73
|
INJECTION
|
0
|
AMP
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
41
|
30612
|
RHOPHYLAC 300MCG INJ (CSL) ANTI-D IMMUNO
|
ANTI-D IMMUNOGLOBULIN
|
RHOPHYLAC
|
2ML AMP
|
BQ
|
122.32
|
122.3246
|
AMP
|
2
|
AMP
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
42
|
3061E
|
RHOPHYLAC 150MCG/ML PREFIL SYRN (CSL) IMMUNOGLOBULIN ANTI-D
|
IMMUNOGLOBULIN ANTI-D
|
RHOPHYLAC
|
1X2ML PFS
|
BQ
|
122.32
|
122.32
|
PFS
|
0
|
PFS
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
|
Add to Contract
|
IV/IM
|
0
|
SERUMS
|
2025-11-10
|
|
|
|
40
|
30827
|
PRIVIGEN 10% INJ (CSL/AHI) IMMUNOGLOBULIN
|
IMMUNOGLOBULIN HUMAN
|
PRIVIGEN
|
50ML
|
BQ
|
951.41
|
951.41
|
INJECTION
|
0
|
BOTT
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
41
|
30827
|
PRIVIGEN 10% INJ (CSL) IMMUNOGLOBULIN (BQ)
|
IMMUNOGLOBULIN HUMAN
|
PRIVIGEN
|
50ML
|
BQ
|
883.46
|
883.4553
|
BOTT
|
50
|
BOTT
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
40
|
30828
|
PRIVIGEN 10% INJ (CSL/AHI) IMMUNOGLOBULIN
|
IMMUNOGLOBULIN HUMAN
|
PRIVIGEN
|
100ML
|
BQ
|
1,413.53
|
1,413.53
|
INJECTION
|
0
|
BOTT
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2022-04-01
|
2022-05-10
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
2022-03-29
|
|
|
|
41
|
30828
|
PRIVIGEN 10% INJ (CSL) IMMUNOGLOBULIN (BQ)
|
IMMUNOGLOBULIN HUMAN
|
PRIVIGEN
|
100ML
|
BQ
|
1766.91
|
1766.9106
|
BOTT
|
50
|
BOTT
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
42
|
3082D
|
PRIVIGEN 10% INJ (CSL) HUMAN IMMUNOGLOBULIN
|
HUMAN IMMUNOGLOBULIN
|
PRIVIGEN
|
100ML
|
BQ
|
1,603.81
|
1,603.81
|
VIAL
|
0
|
BOTT
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
|
Add to Contract
|
IV/IM/SC
|
0
|
SERUMS
|
2025-11-10
|
|
|
|
40
|
30914
|
TETAGAM 250IU INJ (CSL/AHI) TETANUS ANTITOXIN
|
TETANUS ANTITOXIN
|
TETAGAM
|
1ML AMP
|
B
|
67.96
|
67.96
|
INJECTION
|
0
|
AMP
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
41
|
30914
|
TETAGAM 250IU INJ (CSL) TETANUS ANTITOXI
|
TETANUS ANTITOXIN
|
TETAGAM
|
1ML AMP
|
B
|
108.73
|
108.733
|
AMP
|
40
|
AMP
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8012
|
VACCINES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
VACCINES
|
|
|
|
|
42
|
3091J
|
TETAGAM P 250IU/ML PREFIL SYRN (CSL) IMMUNOGLOBULIN HUMAN
|
TETANUS IMMUNOGLOBULIN HUMAN
|
TETAGAM P
|
4X1ML PFS
|
B
|
108.73
|
108.73
|
PFS
|
0
|
PFS
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
|
Add to Contract
|
IM
|
0
|
SERUMS
|
2025-11-10
|
|
|
|
40
|
4582A
|
BERIATE 500IU INJ (CSL/AHI) FACTOR VIII
|
FACTOR VIII
|
BERIATE
|
10ML VIAL
|
BQ
|
244.65
|
244.65
|
INJECTION
|
0
|
VIAL
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202816
|
HEMOSTATICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
4582A
|
BERIATE 500IU INJ (CSL) FACTOR VIII (BQ)
|
FACTOR VIII
|
BERIATE
|
10ML VIAL
|
BQ
|
244.65
|
244.6492
|
VIAL
|
12
|
VIAL
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202816
|
HEMOSTATICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
HEMOSTATICS
|
|
|
|
|
42
|
4582T
|
BERIATE 500IU INJ (CSL) FACTOR VIII
|
FACTOR VIII
|
BERIATE
|
500IU VIAL
|
BQ
|
244.65
|
244.65
|
VIAL
|
12
|
VIAL
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202816
|
HEMOSTATICS
|
2026-04-01
|
|
Add to Contract
|
IV
|
0
|
HEMOSTATICS
|
2025-11-10
|
|
|
|
41
|
49416
|
ALBUREX 20% INJ (CSL) ALBUMIN (BQ)
|
ALBUMIN
|
ALBUREX
|
50ML VIAL
|
BQ
|
73.12
|
73.1229
|
VIAL
|
40
|
VIAL
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IM
|
0
|
SERUMS
|
|
|
|
|
42
|
4941AG
|
ALBURX 25% INJ (CSL) HUMAN ALBUMIN
|
HUMAN ALBUMIN
|
ALBURX
|
50ML VIAL
|
BQ
|
91.06
|
91.06
|
VIAL
|
0
|
VIAL
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
|
Add to Contract
|
IV
|
0
|
SERUMS
|
2025-11-10
|
|
|
|
41
|
4941U
|
ALBUREX 25% INJ (CSL) ALBUMIN (BQ)
|
ALBUMIN
|
ALBUREX
|
50ML VIAL
|
BQ
|
91.06
|
91.0639
|
VIAL
|
40
|
VIAL
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
